X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (80399) 80399
Publication (8549) 8549
Newsletter (6405) 6405
Newspaper Article (3459) 3459
Book Review (931) 931
Book Chapter (538) 538
Dissertation (192) 192
Conference Proceeding (153) 153
Magazine Article (149) 149
Transcript (149) 149
Government Document (110) 110
Book / eBook (73) 73
Web Resource (58) 58
Trade Publication Article (55) 55
Data Set (16) 16
Reference (10) 10
Streaming Video (9) 9
Report (5) 5
Presentation (3) 3
Paper (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
angiogenesis (54285) 54285
humans (50048) 50048
index medicus (42294) 42294
animals (30039) 30039
cancer (21749) 21749
oncology (21485) 21485
female (21393) 21393
male (19972) 19972
mice (16934) 16934
angiogenesis inhibitors (16123) 16123
vascular endothelial growth factor (14774) 14774
expression (13935) 13935
research (12237) 12237
endothelial growth-factor (12159) 12159
angiogenesis inhibitors - therapeutic use (11690) 11690
metastasis (11433) 11433
middle aged (10648) 10648
apoptosis (10495) 10495
care and treatment (9842) 9842
tumors (9636) 9636
aged (9456) 9456
cell biology (8988) 8988
bevacizumab (8841) 8841
analysis (8628) 8628
proteins (8534) 8534
cell line, tumor (8442) 8442
adult (7516) 7516
gene expression (7165) 7165
biochemistry & molecular biology (7158) 7158
angiogenesis inhibitors - pharmacology (6968) 6968
vegf (6870) 6870
cells (6765) 6765
ophthalmology (6670) 6670
growth (6517) 6517
neovascularization (6508) 6508
signal transduction (6366) 6366
chemotherapy (6280) 6280
pharmacology & pharmacy (6184) 6184
health aspects (6162) 6162
kinases (5925) 5925
cells, cultured (5866) 5866
treatment outcome (5573) 5573
rats (5564) 5564
vascular endothelial growth factor a - antagonists & inhibitors (5549) 5549
cell proliferation (5441) 5441
medicine (5403) 5403
therapy (5375) 5375
angiogenesis inhibitors - administration & dosage (5313) 5313
vascular endothelial growth factor a - metabolism (5281) 5281
tumor angiogenesis (5154) 5154
article (5149) 5149
in-vivo (5139) 5139
endothelium (5084) 5084
activation (5035) 5035
inflammation (5021) 5021
hypoxia (4953) 4953
research article (4943) 4943
medicine, research & experimental (4935) 4935
physiological aspects (4861) 4861
in-vitro (4794) 4794
inhibition (4790) 4790
cell proliferation - drug effects (4763) 4763
rodents (4748) 4748
immunohistochemistry (4712) 4712
endothelial cells (4694) 4694
breast cancer (4617) 4617
studies (4453) 4453
development and progression (4418) 4418
multidisciplinary sciences (4369) 4369
neovascularization, pathologic - drug therapy (4343) 4343
cancer therapies (4331) 4331
aged, 80 and over (4157) 4157
proliferation (4086) 4086
medical research (4067) 4067
medicine & public health (3974) 3974
genetic aspects (3925) 3925
prognosis (3860) 3860
mice, nude (3837) 3837
phosphorylation (3831) 3831
antineoplastic agents - therapeutic use (3828) 3828
disease models, animal (3825) 3825
stem cells (3771) 3771
mice, inbred c57bl (3720) 3720
science (3697) 3697
tumor-growth (3648) 3648
carcinoma (3647) 3647
biology (3639) 3639
cell growth (3635) 3635
surgery (3583) 3583
endothelial-cells (3526) 3526
antineoplastic agents - pharmacology (3513) 3513
growth factors (3493) 3493
hematology (3458) 3458
drug therapy (3453) 3453
growth-factor (3446) 3446
macular degeneration (3433) 3433
breast-cancer (3375) 3375
survival (3235) 3235
antibodies, monoclonal, humanized (3188) 3188
dose-response relationship, drug (3186) 3186
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Online Resources - Online (34) 34
Gerstein Science - Stacks (27) 27
Collection Dvlpm't (Acquisitions) - Vendor file (7) 7
Collection Dvlpm't (Acquisitions) - Closed Orders (2) 2
Gerstein Science - Circulation Desk (1) 1
Gerstein Science - Missing (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (1) 1
UofT at Mississauga - Stacks (1) 1
UofT at Scarborough - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (89130) 89130
French (551) 551
German (451) 451
Chinese (337) 337
Japanese (278) 278
Spanish (168) 168
Russian (101) 101
Polish (92) 92
Korean (54) 54
Portuguese (49) 49
Hungarian (37) 37
Czech (36) 36
Italian (23) 23
Romanian (22) 22
Dutch (18) 18
Turkish (14) 14
Swedish (13) 13
Danish (11) 11
Finnish (10) 10
Hebrew (8) 8
Norwegian (6) 6
Persian (5) 5
Slovak (4) 4
Croatian (3) 3
Serbian (3) 3
Ukrainian (3) 3
Icelandic (2) 2
Slovenian (2) 2
Arabic (1) 1
Bosnian (1) 1
Hindi (1) 1
Lithuanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


CA: A Cancer Journal for Clinicians, ISSN 0007-9235, 07/2010, Volume 60, Issue 4, pp. 222 - 243
Angiogenesis has become an attractive target for drug therapy because of its key role in tumor growth. An extensive array of compounds is currently in... 
CELL LUNG-CANCER | TYROSINE KINASE INHIBITORS | PHASE-III TRIAL | FARNESYL-PROTEIN TRANSFERASE | HYPOXIA-INDUCIBLE FACTOR | SUPPRESSES TUMOR-GROWTH | ONCOLOGY | ENDOTHELIAL-GROWTH-FACTOR | FACTOR EXPRESSION | VASCULAR-PERMEABILITY FACTOR | METASTATIC COLORECTAL-CANCER | Neoplasms - metabolism | Nucleic Acid Synthesis Inhibitors - pharmacology | Humans | Receptor Protein-Tyrosine Kinases - physiology | Antibodies, Monoclonal - therapeutic use | Receptors, Notch - antagonists & inhibitors | Protein Binding - drug effects | Angiogenesis Inhibitors - therapeutic use | Receptor Protein-Tyrosine Kinases - antagonists & inhibitors | Neovascularization, Pathologic - prevention & control | Farnesyltranstransferase - antagonists & inhibitors | Thioredoxins - antagonists & inhibitors | Nucleic Acid Synthesis Inhibitors - therapeutic use | Basic Helix-Loop-Helix Transcription Factors - physiology | Antibodies, Monoclonal - pharmacology | Intracellular Signaling Peptides and Proteins - antagonists & inhibitors | Angiogenesis Inhibitors - pharmacology | Receptors, Notch - physiology | Neoplasms - blood supply | Basic Helix-Loop-Helix Transcription Factors - antagonists & inhibitors | Neoplasms - drug therapy | Signal Transduction - drug effects | Cell Transformation, Neoplastic | HSP90 Heat-Shock Proteins - antagonists & inhibitors | Intracellular Signaling Peptides and Proteins - physiology | Complications and side effects | Care and treatment | Ligands (Biochemistry) | Physiological aspects | Development and progression | Dosage and administration | Angiogenesis inhibitors | Neovascularization | Identification and classification | Growth factors | Cancer | Angiogenesis | Pharmacology | FDA approval | Drug therapy | Kinases | Tumors | hypoxia inducible factor (HIF) | kinase inhibitors | growth factors | angiogenesis inhibitors | VEGF | anti-angiogenesis
Journal Article
2009, ISBN 1402095635, ix, 125
In 1971, J. Folkman published in the "New England Journal of Medicine" a hypothesis that tumor growth is angiogenesis-dependent. Folkman introduced the concept... 
Neovascularization | Blood-vessels | Growth | Neovascularization inhibitors | Tumors | Clinical & internal medicine | Treatment | Pathology | History of Science | Biomedicine | Cancer Research | Oncology | Biomedicine general | Cell Biology
Book
2010, Recent results in cancer research, ISBN 9783540782803, Volume 180., xiv, 231
All aspects from the bench to the bedside are considered in this examination of the latest developments in angiogenesis inhibition in cancer. The authors pay... 
Neovascularization inhibitors | Clinical & internal medicine | Chemotherapy | Therapeutic use | Cancer | Oncology | Cancer Research | Medicine & Public Health | Hematology
Book
Cancer Research, ISSN 0008-5472, 05/2005, Volume 65, Issue 10, pp. 3967 - 3979
Journal Article
International Journal of Molecular Sciences, ISSN 1661-6596, 07/2017, Volume 18, Issue 7, p. 1414
Carcinogenesis cannot be explained only by genetic alterations, but also involves epigenetic processes. Modification of histones by acetylation plays a key... 
Histone deacetylase inhibitors | Anti-angiogenic effect | Cell cycle arrest | Drug combinations | Histone deacetylases | Autophagy | Apoptosis | Cancer | HDAC INHIBITORS | autophagy | SUBEROYLANILIDE HYDROXAMIC ACID | HUMAN LEUKEMIA-CELLS | NITRIC-OXIDE SYNTHASE | BIOCHEMISTRY & MOLECULAR BIOLOGY | TUMOR-SUPPRESSOR GENES | apoptosis | VALPROIC ACID | cell cycle arrest | anti-angiogenic effect | CHEMISTRY, MULTIDISCIPLINARY | drug combinations | CELL LUNG-CANCER | EPITHELIAL-MESENCHYMAL TRANSITION | PHASE-II TRIAL | LONG NONCODING RNA | histone deacetylases | cancer | histone deacetylase inhibitors | Immunomodulation - drug effects | Apoptosis - drug effects | Humans | Angiogenesis Inhibitors - pharmacology | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Antineoplastic Agents - therapeutic use | Clinical Trials as Topic | Autophagy - drug effects | Acetylation - drug effects | Animals | Signal Transduction - drug effects | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Cell Cycle Checkpoints - drug effects | Angiogenesis Inhibitors - therapeutic use | Histone Deacetylase Inhibitors - pharmacology | Antineoplastic Agents - pharmacology | Epigenesis, Genetic - drug effects | Histone Deacetylase Inhibitors - therapeutic use | Gene Expression Regulation, Neoplastic - drug effects | Drug Evaluation, Preclinical
Journal Article